US Patent Issued to Deutsches Krebsforschungszentrum on Jan. 13 for "2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer" (German Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,594, issued on Jan. 13, was assigned to Deutsches Krebsforschungszentrum (Germany).

"2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer" was invented by Ilona Gutcher (Berlin), Ulrike Rohn (Berlin), Norbert Schmees (Berlin), Ludwig Zorn (Berlin), Lars Rose (Berlin), Benjamin Bader (Berlin), Christina Kober (Lollar, Germany), Rafael Carretero (Heidelberg, Germany), Detlef Stockigt (Potsdam, Germany), Horst Irlbacher (Berlin) and Michael Platten (Heidelberg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention covers 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamide compounds of general for...